2U3:FRA
Alcon AG
€57.68
arrow_upward
+1.34%(+0.76) 1D
Okt 12, 3:33:08 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 2U3...
Buksan
€56.68
Mataas
€57.68
Mababa
€56.68
Mkt. cap
26.61B
Avg. na dami
130.00
Dami
104.00
Mataas nang 52-wk
€73.96
Mababa nang 52-wk
€51.78
Bilang ng mga empleyado
25K
Buksan
€56.68
Mataas
€57.68
Mababa
€56.68
Mkt. cap
26.61B
Avg. na dami
130.00
Dami
104.00
Mataas nang 52-wk
€73.96
Mababa nang 52-wk
€51.78
Bilang ng mga empleyado
25K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
7 oras ang nakalipas
Alcon posts 256-patient data while Alcon stock sits 21.38 percent below its high
ad-hoc-news.de
·
23 oras ang nakalipas
Alcon highlights AAO innovation as Alcon stock sits at EUR 57.28
Simply Wall Street
·
2 araw ang nakalipas
What Alcon Shares Launch Of New Dry Eye Drops In Canada Means For Shareholders
ad-hoc-news.de
·
2 araw ang nakalipas
Alcon stock is unchanged at EUR 57.25 as AAO 2026 begins
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Tungkol sa Alcon AG
CEODavid J. Endicott
Mga Empleyado25K
Itinatag1945
HeadquartersHinebra, Geneva, Switzerland
Sektor-
Websitealcon.com